“This patent filing marks an important milestone in strengthening the protection of our technology,” said Lawrence Law, ...

Akari Therapeutics (AKTX) announced that it has filed two new provisional patent applications with the United States Patent ...

The Company continues to expand its current ADC pipeline to encompass multiple targets, such as AKTX-101 (Trop2 ADC with PH1 ...

This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer .

Nutriband files provisional patent application to enhance its AVERSA™ transdermal abuse deterrent technology being developed for patches containing opioids and stimulants with a potential for abuse.

The technology uses high temperatures and resin systems to recover metal concentrates from semiconductor acid waste.

The Federal Circuit held that provisional application language omitted from the final patent cannot support broader claim interpretations. Courts may treat changes and omissions between provisional ...

As Kennesaw State University strives to conduct research with relevant societal impact, it remains essential to provide ...

LegalZoom’s law firm to provide affordable patent protection through intelligent technology and licensed patent attorneys at a fraction of traditional costs LegalZoom.com, Inc. (Nasdaq: LZ), a leading ...

Atlanta, GA, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Trust Stamp announces a groundbreaking innovation in biometric security with the allowance by the United States Patent and Trademark Office of a patent ...

Files Provisional Patent To Strengthen Protection Of AVERSA(TM) Abuse-Deterrent Technology. Nutriband (NASDAQ: NTRB) , a developer of prescription transdermal pharmaceutical products, announced the ...